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ABSTRACT 27 
Background: Malnutrition is common in patients with chronic obstructive pulmonary disease 28 
(COPD). This study aimed to explore its association with all-cause mortality, emergency 29 
hospitalisation and subsequently healthcare costs. 30 
Methods: A prospective cohort observational pilot study was carried out in outpatients with COPD 31 
that attended routine respiratory clinics at a large tertiary Australian hospital during 2011. 32 
Electronic hospital records and hospital coding was used to determine nutritional status and whether 33 
a patient was coded as nourished or malnourished and information on healthcare use and 1-year 34 
mortality was recorded.  35 
Results: Eight hundred and thirty four patients with COPD attended clinics during 2011, of those 36 
286 went on to be hospitalised during the 12 month follow-up period. Malnourished patients had a 37 
significantly higher 1-year mortality (27.7% vs. 12.1%; p = 0.001) and were hospitalised more 38 
frequently (1.11 SD 1.24 vs. 1.51 SD 1.43; p = 0.051). Only malnutrition (OR 0.36 95% CI 0.14-39 
0.91; p = 0.032) and emergency hospitalisation rate (OR 1.58 95% CI 1.2-2.1; p = 0.001) were 40 
independently associated with 1-year mortality. Length of hospital stay was almost twice the 41 
duration in those coded for malnutrition (11.57 SD 10.93 days vs. 6.67 SD 10.2 days; p = 0.003) 42 
and at almost double the cost (AUD $23,652 SD $26,472 vs. $12,362 SD $21,865; p =0.002) than 43 
those who were well-nourished 44 
Conclusion: Malnutrition is an independent predictor of 1-year mortality and healthcare use in 45 
patients with COPD. Malnourished patients with COPD present both an economic and operational 46 
burden.   47 
 48 
 49 
 50 
 51 
 52 
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INTRODUCTION 53 
Disease-related malnutrition is a common problem and presents a significant clinical, economic and 54 
operational burden to healthcare systems worldwide. Malnutrition has been suggested to attribute to 55 
an increase in hospitalisation costs of 20% [1].  In patients with COPD, up to 60% of inpatients and 56 
45% of outpatients have been found to be at risk of malnutrition [2]. According to the Australasian 57 
Nutrition Care Day Survey conducted in 56 hospitals across Australia and New Zealand, the overall 58 
prevalence of malnutrition was 32% [3]. A previous study also involving 56 hospitals, included 59 
6150 Dutch patients and found a quarter of patients to be malnourished but less than half were 60 
identified [4]. Malnutrition is associated with several negative clinical outcomes as patients usually 61 
have prolonged convalescence from illness, increased length of hospital stay (LOS) and mortality [5 62 
6]. Whilst the negative association between nutritional depletion and mortality in COPD is well 63 
known [7], the association between malnutrition, healthcare use and the subsequent healthcare costs 64 
associated with it in COPD patients has not been fully explored.   65 
In Australia, COPD is ranked as having the third highest burden of disease in terms of disability-66 
adjusted life years (DALYs) [8] and affects about 14.5% of all Australian adults above the age of 40 67 
[9]. In 2008-2009, health expenditure directly attributed to COPD in Australia was estimated at 68 
$929 million [8] highlighting the economic burden of COPD to the Australian healthcare system. 69 
The main treatment goals of COPD are to delay disease progression and reduce the frequency of 70 
infective exacerbations [10]. Research has suggested that poor health-related quality of life is 71 
associated with the frequency of COPD exacerbations  [11] and which is likely to be  linked to 72 
frequent periods of hospitalisation. In 608 COPD patients hospitalised for an exacerbation in the 73 
United Kingdom, patients with a deteriorating nutritional status, indicated by unintentional weight 74 
loss exceeding 10% within the 3-6 months preceding the admission, were almost 4-times more 75 
likely to be readmitted early [12]. In addition, those patients with a body mass index (BMI) <18.5 76 
kg/m2 were twice as likely to die during the admission. It is likely that malnutrition is a significant 77 
driver of the large burden of COPD to healthcare systems. In the United States it has been estimated 78 
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that about 88% of the total direct health expenditure attributed to COPD is associated with acute 79 
and ambulatory hospital services [13]. In Australia, inpatient hospital services account for more 80 
than half of the direct health expenditure attributed to COPD[ 8] but to what extent this healthcare 81 
use is driven by disease-related malnutrition is unclear. Therefore, this study explored the 82 
association between malnutrition in hospitalised COPD patients and its impact on mortality, 83 
hospital healthcare use and the subsequent healthcare costs.  84 
 85 
 86 
METHODS 87 
Study Subjects and Study Design 88 
This study utilised electronic hospital records to identify all of those patients that attending the 89 
Respiratory Laboratory at Princess Alexandra Hospital for pulmonary function testing during 2011.  90 
All patients who had undertaken at least one lung function test during routine respiratory outpatient 91 
clinic attendance with a confirmed diagnosis of COPD were included. COPD patients were 92 
identified based on FEV1/FVC <0.7 and FEV1 <100% predicted. The nutritional status of patients 93 
was identified through the diagnosis-related group (DRG) for malnutrition recorded in the hospital 94 
records.  95 
Demographic and clinical information such as age, gender, body mass index (BMI), lung function 96 
(%FEV1, %DLCO), and COPD disease severity according to Global Initiative for Chronic 97 
Obstructive Lung Disease (GOLD) classification [14] were collected. Additionally, malnutrition 98 
status, 1-year healthcare use and admission data (emergency and elective hospitalisation rate and 99 
subsequent duration of hospital stay (LOS) and associated costs (AUD$)) as well as 1- and 2-year 100 
mortality were collected using electronic hospital records. BMI was classified as underweight 101 
(<21kg/m2), normal weight (21-25 kg/m2), overweight (>25-30 kg/m2) and obese (>30 kg/m2) 102 
categories according to the American Thoracic Society/ European Respiratory Society Task Force 103 
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[15]. Ethical approval for the study was awarded from the hospital Human Research Ethics 104 
Committee and Governance Unit and the Queensland University of Technology (QUT) Research 105 
Ethics Unit (TPCH: HREC/13/QPCH/220, QUT: 1300000774).  The reporting of this paper also 106 
conforms to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 107 
recommendations [16] 108 
Nutrition Assessment 109 
In order to receive a DRG code for malnutrition, patient’s nutritional status was assessed using the 110 
Subjective Global Assessment (SGA) tool [17] and was completed by a dietitian. The SGA is a 111 
validated nutrition assessment tool which involves a clinical domain: assessing weight and dietary 112 
intake changes over a period of time, nutrition impact symptoms, functional capacity and a physical 113 
assessment domain: assessing fat and muscle wasting, the presence of nutritionally-related oedema 114 
and a patient’s functional capacity [17]. The SGA categorises patients into three groups, well-115 
nourished, mild/moderately malnourished and severely malnourished. Patients diagnosed as 116 
malnourished (mild/moderately or severely malnourished) during their hospital admission were 117 
coded as such using the relevant DRG code.  118 
Healthcare Use 119 
Hospital admission data (frequency, LOS, type (emergency or elective)) and costs were also 120 
collected from electronic hospital records. Costs related to each hospital admission were estimated 121 
using the institution’s own health economics modelling techniques which derive costs from DRG 122 
codes. All costs were recorded in Australian Dollars (AUD$). 123 
Statistical Analysis 124 
Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) for 125 
Windows Version 20 (SPSS Inc., Chicago, IL, USA). Continuous variables such as LOS and costs 126 
are presented as mean ± standard deviation (SD), unless otherwise stated. Categorical variables 127 
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such as malnutrition status and 1-year mortality are presented as n (%). A p-value ≤ 0.05 was 128 
considered statistically significant.  129 
Differences between two categorical variables were tested using Pearson’s chi-square test. Further 130 
statistical analyses using purposeful selection with binary logistic regression were also used to 131 
predict odds ratios with the associated 95% confidence interval (95% CI) which allowed adjustment 132 
for potential confounders associated with mortality. Differences between a categorical and 133 
continuous variable were evaluated by comparing their mean ± SD using one-way ANOVA test. 134 
Interrogation of the data in this manner allowed identification of independent associations between 135 
malnutrition status, healthcare use, mortality and healthcare costs. 136 
RESULTS 137 
Patient Characteristics 138 
A convenience sample of 834 unique outpatients with a confirmed diagnosis of COPD was 139 
obtained. Of those outpatients, 286 went on to experience at least one hospitalisation within a year 140 
of their test date which allowed their nutritional status to be identified (Figure 1). Characteristics of 141 
the patients included are described in Table 1. Compared to those patients that were not hospitalised 142 
(n = 548) the patients included in the study (n = 286) were significantly older (mean age 66.6 SD 143 
11.0 years vs. 64.8 SD 11·7 years; p = 0.030) and had a significantly lower BMI (mean BMI 27.4 144 
SD 6.6 kg/m2 vs. 28.6 SD 7.3 kg/m2; p = 0.016) using ANOVA analysis. No differences in lung 145 
function between the two groups were observed in terms of Forced Expiratory Volume in 1 second 146 
(FEV1), Diffusing Capacity of the lungs for carbon monoxide (DLCO), FEV1/FVC ratio, and 147 
Residual Volume (RV). Patients coded as malnourished had a significantly lower BMI and there 148 
was a trend to be older and have a lower diffusing capacity of the lung (Table 1).  149 
 150 
 151 
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Table 1: Patient characteristics 152 
Variables Nourished 
(n 239)  
Malnourished 
(n 47) 
p-value 
Male (%): Female (%)  160 (67%):79 (33%) 34 (72%):13 (28%) 0.469 
Age (years) 66.1 (11.3) 69.5 (8.7) 0.054 
BMI (kg/m2) 28.2 (6.6) 23.6 (5.4) <0.001* 
FEV1 (% predicted) 64.4 (19.6) 60.8 (20.5) 0.260 
RV (% predicted) 119.1 (41.0) 123.0 (50.0) 0.691 
DLCO (% predicted) 64.4 (20.0) 57.4 (17.6) 0.063 
 153 
Results reported are mean (SD) using ANOVA with the exception of age (X2); BMI = Body Mass 154 
Index; FEV1 = Forced Expiratory Volume in 1s; RV = Residual Volume; DLCO = Diffusing 155 
Capacity of the Lung for Carbon Monoxide; * p < 0.05.  156 
 157 
Malnutrition and mortality 158 
Compared to the nourished patients, patients classified as malnourished had a significantly higher 159 
mortality rate at 1-year (27.7% vs. 12.1%; p = 0.006) and this remained the case at 2-years (40.4% 160 
vs. 18%; p = 0.001; X2 analysis). As the malnourished patients tended to be older and have poorer 161 
pulmonary function, binary logistic regression analysis was conducted using purposeful selection 162 
adjusting for potential confounders by exploring the whole cohort of 834 outpatients. Age (p 163 
<0.001), % FEV1 (p = 0.019), BMI (p = 0.073) and % DLCO (p = 0.062) were all identified as 164 
potential confounders with p values <0.2 and adjusted for within the analysis (Table 2). 165 
Malnutrition was found to be a strong independent predictor of 1-year mortality with malnourished 166 
patients having almost three times the odds of dying within a year of their initial presentation (OR 167 
2.93 95% CI 1.10, 7.93; p = 0.009). Other than malnutrition, the only other variable found to be 168 
significantly and independently associated with 1-year mortality was emergency hospitalisation 169 
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rate.  BMI, %FEV1, %DLCO, COPD severity and age were not associated with 1-year mortality in 170 
regression analysis.   171 
Table 2: Binary logistic regression for predictors of 1-year mortality  172 
Variables Odds Ratio [95%CI] p-value 
Number of Emergency Admissions 1.55 [1.19, 8.69] <0.001* 
Malnutrition 2.93 [1.10, 7.93] 0.009* 
Age 1.04 [0.99, 1.10] 0.120 
BMI 0.99 [0.97, 1.02] 0.484 
% DLCO 0.99 [0.97, 1.02] 0.507 
% FEV1 0.98 [0.92, 1.04] 0.610 
COPD disease-severity (GOLD) 0.59 [0.13, 2.67] 0.935 
 173 
BMI = Body Mass Index; FEV1 = Forced Expiratory Volume in 1s; DLCO = Diffusing Capacity of 174 
the Lung for Carbon Monoxide; * p < 0.05.  175 
 176 
Similar results were obtained when analysis of time to event was performed using cox-regression 177 
survival analysis (Figure 2). Malnutrition (OR 0.42 95% CI 0.19 to 0.91; p = 0.028) and emergency 178 
hospitalisation rate (OR 1.37 95% CI 1.15 to 1.62; p < 0.001) remained significant independent 179 
predictors of mortality. 180 
 181 
Malnutrition and costs associated with hospitalisation 182 
Following emergency hospital admission, malnourished patients were found to have a significantly 183 
longer LOS than nourished patients; mean LOS 11.57 SD 10.94 days vs. 6.67 SD 10.21 days; 184 
difference +4.9 SE 1.65 days 95%CI 1.65-8.15 days; p = 0.003.  Similar results were also found 185 
when emergency and elective lengths of stay were combined (malnourished 22.51 SD 19.40 days 186 
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vs. nourished 11.26 SD 14.67 days; difference +11.3 SE 2.48 days 95%CI 6.4-16.1 days; p<0.001). 187 
With malnourished patients remaining hospitalised for almost twice the duration as nourished 188 
patients, the resulting costs were also significantly higher in the malnourished group; mean cost 189 
$23,652 SD $26,472 vs. $12,362 SD $21,865; difference +$11,290 SE $3,618 95%CI $4,168-190 
$18,411; p = 0.002 (Figure 3). Similar results were also found when analysing the costs associated 191 
with non-emergency admissions (malnourished $38,833 SD $25,770 vs. nourished $21,468 SD 192 
$27,747; difference +$17,365 SD $4,659 95% CI $8,195-$26,535; p<0.001). 193 
DISCUSSION 194 
This is the first study to evaluate the impact of malnutrition on hospitalisation, healthcare costs and 195 
mortality in patients with COPD. Malnutrition was found to be a significant and independent 196 
predictor of mortality, with malnourished patients almost three times greater odds of dying within a 197 
year. Whilst the negative association between nutritional depletion and survival in COPD is well 198 
known, previous survival analysis has shown that appropriate nutritional therapy resulting in weight 199 
gain is associated with improved survival [18]. However, it is yet to be established whether 200 
improved survival following the treatment of malnutrition is also associated with reduced healthcare 201 
use. In the current study, patients coded as malnourished during their hospital admission remained 202 
hospitalised for almost twice the duration as their nourished counterparts, at almost double the cost. 203 
Whilst previous studies have not formally diagnosed malnutrition, they have reported nutrition 204 
status, defined by various means, to be associated with increased mortality and healthcare use.  In a 205 
study of patients requiring long-term oxygen therapy, a BMI <20 kg/m2 was found to be an 206 
independent risk factor for increased mortality and hospitalisation [19]. Analysis of COPD patients 207 
from the Copenhagen City Heart Study reported BMI to be independently associated with all-cause 208 
mortality [20]. More recent retrospective cohort study involving over 300,000 COPD hospital 209 
admissions discovered obese patients to have lower in-hospital mortality and a lower risk of early 210 
readmission compared to non-obese patients [21]. The authors also found that non-obese patients 211 
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had a considerably higher risk of mortality during hospitalisation and readmission within 30 days of 212 
discharge. However, full nutritional assessment and malnutrition status was not assessed.  213 
With an increased focus on reducing the duration of hospital stay and avoidance of hospital 214 
readmission, all but the sickest patients are managed in the outpatient setting. This reduces the 215 
opportunity within which hospitalised COPD patients at nutritional risk can be identified, seen by a 216 
dietitian for nutritional assessment and the initiation and evaluation of individualised nutritional 217 
support. In order for this to occur, robust policies documenting the nutritional management of 218 
COPD patients are required. The first step is for malnourished patients to be promptly identified, 219 
either in the community or on admission. Whilst there is currently no universally accepted method 220 
for the identification of malnutrition, there are several validated nutritional screening and 221 
assessment tools available. Most nutritional screening tools involve an assessment of recent 222 
unintentional weight loss and BMI is also often recommended as a routine marker of nutritional 223 
status [22 23]. However, there is no consensus around what the BMI cut-off for nutritional risk in 224 
COPD should be, with recommendations of <20 kg/m2 (NICE [23]) and <21 kg/m2 (ATS/ERS [22] 225 
and BODE index [20 24]). In addition, it appears that there are currently no guidelines around the 226 
management of COPD that formally recommend routine nutritional screening and nutritional 227 
assessment. Whilst BMI has good predictive validity for survival and hospitalisation [19] and is a 228 
pragmatic measurement routinely advocated by guidelines, it is not without its limitations. 229 
Depletion of fat-free mass that is common in COPD [25] can be masked by an expansion of fat-230 
mass impacting on the sensitivity of BMI as a marker of nutritional depletion and risk. This was 231 
highlighted in a study of 300 outpatients with COPD where a BMI <20 kg/m2 was reported in 17% 232 
of patients but more than double (38%) had fat-free mass depletion [26]. If BMI alone is used as a 233 
method of identifying nutritional risk, a significant proportion of patients would go unidentified. 234 
Indeed, a recent review by Schols et al., [27] suggests that fat-free mass might be a better predictor 235 
of mortality in COPD patients than BMI alone. The current study found BMI to be a less sensitive 236 
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predictor of survival, rather rate of emergency hospitalisation and comprehensive nutritional 237 
assessment allowing diagnosis of malnutrition had much stronger associations with poor survival.  238 
The current findings that malnourished COPD patients experience greater emergency healthcare use 239 
and longer durations of hospital stay are consistent with previous studies in other patient groups that 240 
have reported prolonged LOS [28-30], higher rate of readmission rates[ 28 29], increased pressure 241 
ulcer incidence and delayed wound healing [5 31]. However, it is often thought that malnutrition is 242 
a consequence of the progressive pathophysiology associated with COPD; with those with the more 243 
severe disease having poorer respiratory function and elevated inflammatory processes contributing 244 
towards the development of malnutrition and subsequent poorer survival [7]. The current study 245 
attempted to account for this by adjusting for COPD disease severity, age and lung function, finding 246 
that only malnutrition and emergency hospitalisation rate to be independently associated with 247 
poorer survival. Due to the observational nature of the study, it is the difficult to establish exact 248 
causation between the two independent predictors and whether patients are more likely to become 249 
malnourished following recurrent bouts of emergency hospitalisation or whether those patients with 250 
malnutrition more likely to have infective exacerbations of COPD requiring hospitalisation. The 251 
aetiology of malnutrition in COPD is multi-factorial and complex and both are likely to be related. 252 
However, recent systematic review and meta-analyses have shown that if malnutrition is identified 253 
in COPD, it is amenable to treatment, resulting in significantly improved nutritional status, 254 
functional capacity and associated with improvements of quality of life [32 33]. Interestingly, the 255 
reviews found that nutritional support in stable COPD outpatients resulted in an increase in body 256 
weight of approximately 2kg and it is this level of weight gain that has previously been associated 257 
with improved survival in malnourished COPD patients [18]. Whilst the evidence base for 258 
nutritional intervention in stable (non-exacerbating) outpatients with COPD is strong, it is almost 259 
entirely based on liquid pre-prepared oral nutritional supplements (ONS). There is limited evidence 260 
demonstrating the effectiveness of other forms of nutritional intervention such as fortified meals 261 
and dietary counselling provided by a dietitian. However, this lack of evidence does not indicate a 262 
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lack of effect. Also, few studies have attempted to investigate the effectiveness of nutritional 263 
support in acutely unwell hospitalised COPD patients. One reason for this is the difficulty in 264 
intervening in an acute unwell population with a relatively short length of admission. Whilst the 265 
average hospital length of stay for the nourished patients in the current study was less than a week, 266 
the malnourished patients tended to stay on average 5 days longer. Vermeeren et al., [34] found that 267 
whilst nutritional support using ONS was able to significantly increase energy and in particular 268 
protein intake during the average 9 days admission period it did not lead to any improvements 269 
above that of the control group. The authors highlight the difficulty in achieving theoretical 270 
nutritional requirements during an infective exacerbation through the normal hospital diet alone 271 
without nutritional support. It is likely that nutritional interventions need to be longer in duration for 272 
improvements to be seen with studies in stable COPD outpatients usually lasting between 8-12 273 
weeks [33]. A previous study by Weekes et al., [35] involving stable malnourished outpatients with 274 
COPD found dietetic counselling over 6 months not only resulted in significant improvements in 275 
nutritional status and quality of life but these improvements remained at 12 months. However, 276 
further research is needed to establish whether nutritional interventions initiated promptly on 277 
admission in malnourished COPD patients, and continued for an appropriate period of time, can 278 
lead to improvements in nutritional status and reduced subsequent healthcare use and costs.  279 
Whilst the current study involved a large enough sample size to perform regression analysis 280 
adjusting for confounders, it isn’t without limitations. Although a large sample, it is from a single 281 
large tertiary hospital. Therefore extrapolation of results should be done with caution. Electronic 282 
medical record data on hospitalisation and duration of stay was only available for that hospital site 283 
and if patients were admitted to surrounding hospitals this information would not have been 284 
captured. The current sample was also limited by the fact that comprehensive nutritional assessment 285 
and the diagnosis of malnutrition was only possible in those patients admitted to hospital. Current 286 
local policy meant that routine nutritional screening was not part of outpatient clinical 287 
appointments. The prevalence of malnutrition in the 286 patients that went on to experience a 288 
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hospital admission in the current study at 16%, whilst this is comparable to previous rates reported 289 
of 19%[36] and 24% [37] these studies used a BMI threshold of <20 kg/m2. As the current study 290 
used full nutritional assessment using the Subjective Global Assessment, 16% would appear to be 291 
an underestimate of the true malnutrition prevalence. In a study that used BMI and assessment of 292 
FFM to diagnose malnutrition the prevalence was 38% [38]. It is possible patients were not 293 
documented on the electronic hospital records as malnourished, this is common in COPD and has 294 
been found to be the case in another Australian hospital [39]. However, it is felt that undiagnosed 295 
malnutrition in the current study will only have had the potential to reduce the magnitude of the 296 
current estimates and we feel the conclusions would remain unchanged.   297 
In conclusion, disease-related malnutrition in COPD is independently associated with a significant 298 
clinical, economic and operational burden to hospitals. Malnutrition and emergency hospitalisation 299 
was also associated with poorer survival. Whilst malnutrition in COPD patients has been found to 300 
be amenable to treatment through nutritional support, the evidence is almost entirely based on stable 301 
outpatients and it is hoped future well-designed prospective nutritional intervention studies will 302 
explore the impact of early nutritional assessment and nutritional interventions on clinical and 303 
economic outcomes.      304 
 305 
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